���构特征与受体作用机制 — What the Evidence Shows

By Editorial Desk · published 2025-10-23 · last reviewed 2025-12-01 · Info

The short version of GLP-1 receptor agonist fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-12-01 and is reviewed periodically as new material appears.

结构特征与受体作用机制

皮下注射后吸收相对缓慢，绝对生物利用度约为百分之八十九，血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢，终末半衰期约为一百六十五小时，接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升，血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主，相关产物主要经尿液与粪便排出。

序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。

Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物，其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代，使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸，进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链，该侧链赋予分子与血浆白蛋白结合的能力。

Peptide Background and Receptor Mechanism

Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.

The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.

Semaglutide at a glance

Background and Drug Class

Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.

Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.

Related pages on this site

• Automated casebook
• Quality briefing
• Simple review
• Smart reference
• Measured summary
• Portable collection
• Reliable dataset
• Portable trends

Background and Molecular Profile

Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.

The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L cells after food intake. The molecule is a 31-amino-acid backbone modified at three positions to resist cleavage by dipeptidyl peptidase-4, the enzyme that degrades native GLP-1 within minutes. A lysine residue at position 26 carries a linker and a C18 fatty diacid, which promotes binding to serum albumin and slows renal clearance. These changes extend the circulating half-life from roughly two minutes to about one week in humans.

Mechanism and Pharmacological Class

Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.

Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.

Background from the literature

When the reagent is methane, the predominant reaction is proton transfer M + CH5+ → (MH)+ + CH4. When the reagent is ammonium, the predominant reaction is proton transfer M + NH4+ → (MH)+ + NH3. When the reagent is isobutane, the reaction may be proton transfer M + (CH3)3C+ → (MH)+ + (CH3)2C=CH2 or adduct formation M + (CH3)3C+ → (M · C(CH3)3)+. CI can also produce negatively charged analyte ions by proton abstraction or adduct formation. For example, ionized NF3 contains F−, which abstracts proton.

According to scholar Ray Jabre Mouawad, the Druze appreciated the two saints for their bravery, Saint George because he confronted the dragon and the Prophet Elijah because he competed with the pagan priests of Baal and won over them. In both cases the explanations provided by Christians are that Druzes were attracted to warrior saints that resemble their own militarized society. Saint George is considered the patron saint of Lebanese Christians, Palestinian Christians, Syrian Christians, and the Druze. Salman the Persian is honored as a prophet in the Druze faith, and as an incarnation of the monotheistic idea. As a practicing Zoroastrian, he dedicated much of his early life to studying to become a magus, though he later became preoccupied with travelling throughout Western Asia to engage in interfaith dialogue with other religious groups. His quests eventually prompted his conversion to Christianity and later his conversion to Islam, which occurred after he met and befriended Muhammad in the city of Yathrib. In 587 he met a Nestorian Christian group and was impressed by them. Against the wishes of his father, he left his family to join them. His family imprisoned him afterwards to prevent him but he escaped.

Surgeons performing an amputation have to first ligate the supplying artery and vein, so as to prevent hemorrhage (bleeding). The muscles are transected, and finally, the bone is sawed through with an oscillating saw. Sharp and rough edges of bones are filed, and skin and muscle flaps are then transposed over the stump, occasionally with the insertion of elements to attach a prosthesis.

Sources: en.wikipedia.org

Reference notes

Blood clotting is measured using standard tests, e.g. prothrombin time, partial thromboplastin time, thrombin time, and/or reptilase time. Low fibrinogen levels and dysfunctional fibrinogens usually prolong these times, whereas the lack of fibrinogen (i.e. afibrinogenemia) renders these times infinitely prolonged. Fibrinogen levels are measured in the plasma isolated from venous blood by immunoassays, or through clotting assays such as the Clauss fibrinogen assay or prothrombin based methods. Normal levels being about 1.5-3 g/L, depending on the method used. These levels are normal in dysfibrinogenemia (i.e. 1.5-3 g/L), decreased in hypofibrinogenemia and hypodysfibrinogenemia (i.e. <1.5 g/L), and absent (i.e. <0.02 g/L) in afibrinogenemia. Functional levels of fibrinogen are measured on plasma induced to clot. The levels of clotted fibrinogen in this test should be decreased in hypofibrinogenemia, hypodysfibrinogenemia, and dysfibrinogenemia and undetectable in afibrinogenemia. Functional fibrinogen/antigenic fibrinogen levels are <0.7 g/L in hypofibrinogenemia, hypodysfibrinogenemia, and dysfibrogenemia, and not applicable in afibrinogenemia. Fibrinogen analysis can also be tested on whole-blood samples by thromboelastometry. This analysis investigates the interaction of coagulation factors, their inhibitors, anticoagulant drugs, and blood cells (specifically, platelets), during clotting and subsequent fibrinolysis as it occurs in whole blood.

The Sports Authority of India has started coaching in football, hockey, and basketball for students. Students take part in mountaineering, rock climbing, trekking and adventure camps at hill stations and mountaineering institutes.

In immunology, an adjuvant is a substance that increases or modulates the immune response to a vaccine. The word "adjuvant" comes from the Latin word adiuvare, meaning to help or aid. "An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens." In the early days of vaccine manufacture, significant variations in the efficacy of different batches of the same vaccine were correctly assumed to be caused by contamination of the reaction vessels. However, it was soon found that more scrupulous cleaning actually seemed to reduce the effectiveness of the vaccines, and some contaminants actually enhanced the immune response. There are many known adjuvants in widespread use, including potassium alum, various plant and animal derived oils and virosomes.

Multiple experts have since challenged the prosecution's interpretation of the medical evidence, arguing that the infants' deaths were explainable by natural causes. The Criminal Cases Review Commission is considering referring the case back to the Court of Appeal.

Sources: en.wikipedia.org

Notes from published material

In November 2025, senator Mark Kelly and five other Democratic Congress members participated in a video, telling military personnel to defy "illegal orders". Trump said those in the video were traitors who should be charged with sedition and shared a social media post that called for them to be hanged. The Pentagon announced that Kelly was under investigation after it received "serious allegations of misconduct" in relation to the "illegal orders" video. Puerto Rico governor Jennifer Gonzalez thanked the Trump administration on 9 September 2025 for the "fight against drug cartels in our hemisphere". Susie Wiles, Trump's White House Chief of Staff, said that Trump would "keep on blowing boats up until Maduro cries uncle." Representatives Joaquin Castro and Sara Jacobs released a letter in March 2026 in support of an Inter-American Commission on Human Rights investigation into the legality of the strikes. In November 2025, it was reported that the Committee on Armed Services in the House and Senate had opened inquiries into the strikes. In December 2025, the House reportedly ended its inquiry. The same month, POLITICO reported that the Senate's inquiry was proceeding. The National Defense Authorization Act for Fiscal Year 2026 conditions pentagon funding on the secretary of defense providing the House and Senate committees unedited video of the strikes. In May 2026, after stalling, the Department of Defense Office of Inspector General opened an investigation.

== Growth == The optimal growth temperature range for B. cereus is 30–40 °C (86–104 °F). At 30 °C , a population of B. cereus can double in as little as 20 minutes or as long as 3 hours, depending on the food product. Spores of B. cereus are not metabolically active, but can rapidly become active and begin replicating once they encounter adequate growth conditions.

costmary, 1–66 grams sweet flag, 20 grams hypericum, 8 grams Natural gum, 8 grams sagapenum, 8 grams acacia juice, 8 grams Illyrian iris (probably I. germanica), 8 grams cardamom, 8 grams anise, 12 grams Gallic nard (Valeriana italica), 16 grams gentian root, 16 grams dried rose leaves, 16 grams poppy-tears (Papaver rhoeas, a wild poppy with low opiate content), 17 grams parsley, 17 grams cassia, 20–66 grams saxifrage, 20–66 grams darnel, 20–66 grams long pepper, 20–66 grams storax, 21 grams castoreum, 24 grams frankincense, 24 grams hypocistis juice, 24 grams myrrh, 24 grams opopanax, 24 grams malabathrum leaves, 24 grams flower of round rush, 24–66 grams turpentine-resin, 24–66 grams galbanum, 24–66 grams Cretan carrot seeds, 24–66 grams nard, 25 grams opobalsam, 25 grams shepherd's purse, 25 grams rhubarb root, 28 grams saffron, 29 grams ginger, 29 grams cinnamon, 29 grams The ingredients are then "pounded and taken up in honey. Against poisoning, a piece the size of an almond is given in wine. In other affections an amount corresponding in size to an Egyptian bean is sufficient." Of these ingredients, Illyrian iris, darnel, and rhubarb were not commonly found in other versions of the antidote. However, Celsus' formulation, written 100 years after the death of Mithridates, was one of the first published. Galen called the antidote "theriac" and presented versions by Aelius (used by Julius Caesar), Andromachus (physician to Nero), Antipater, Nicostratus, and Damocratis. The Andromachus formulation closely resembles that of Celsus.

=== Economics === Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. Sales rose to $31.2 million in the first quarter of 2012. The total cost for the first year of treatment with belimumab is $28,000. Belimumab is much more expensive than other drugs used to treat lupus, including prednisone ($140 per year), hydroxychloroquine ($132), oral methotrexate ($432), azathioprine ($468), and mycophenolate mofetil ($1,224). In the United Kingdom, the National Institute for Health and Care Excellence calculated the cost of belimumab at £61,200 per quality-adjusted life year (QALY). This is more than the normally accepted cost of £20,000 to £30,000 per QALY. The manufacturer offered the UK National Health Service a discount of a confidential amount, which still did not bring it into the acceptable range.

Hegseth's former sister-in-law, Danielle, sent an affidavit to senators alleging that he was abusive to his second wife, Samantha, and that he had issues with over-consumption of alcohol. Hegseth denied having a drinking problem and pledged not to drink if confirmed. On January 24, Hegseth was confirmed by the Senate in a 51–50 vote. Every Republican senator, with the exception of Susan Collins, Lisa Murkowski, and Mitch McConnell, voted to confirm him, while every Democratic senator opposed his nomination, leading to a 50–50 vote. Vance cast a tie-breaking vote to confirm Hegseth. His confirmation was threatened by Senator Thom Tillis, who told Senate majority leader John Thune the day before that he would not vote for Hegseth on the basis of his sexual assault allegations. Persuaded by Vance, Tillis expressed support for Hegseth on X minutes before the vote. His confirmation was the second in US history to be decided by a vice president, after Betsy DeVos's confirmation for secretary of education in 2017.

Sources: en.wikipedia.org

Frequently asked questions